Synapse - Works

Results (5612)

The prognostic significance of white adipose tissue inflammation in advanced-stage, high-grade, and serous endometrial cancers

Meeting Abstract

Broach, V.; Iyengar, N. M.; Zhou, X. K.; Wang, H.; Giri, D. D.; Williams, S.; Abu-Rustum, N.; Rubinstein, M. M.; Dannenberg, A. J.; Makker, V.
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Managing cytokine release syndrome (CRS) and neurotoxicity with step-fractionated dosing of mosunetuzumab in relapsed/refractory (R/R) B-cell non-Hodgkin lymphoma (NHL)

Meeting Abstract

Bartlett, N. L.; Sehn, L. H.; Assouline, S. E.; Bosch, F.; Diefenbach, C. S. M.; Flinn, I.; Hong, J.; Kim, W. S.; Matasar, M. J.; Nastoupil, L. J.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Prospective randomized phase II trial of pazopanib versus placebo in patients with progressive carcinoid tumors (CARC) (Alliance A021202)

Meeting Abstract

Bergsland, E. K.; Mahoney, M. R.; Asmis, T. R.; Hall, N.; Kumthekar, P.; Maitland, M. L.; Niedzwiecki, D.; Nixon, A. B.; O'Reilly, E. M.; Schwartz, L. H.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Phase 1/2 dose-escalation and expansion study investigating SAR439859+/- palbociclib in postmenopausal women with estrogen receptor-positive (ER+)/HER2- metastatic breast cancer

Meeting Abstract

Bardia, A.; Linden, H. M.; Ulaner, G. A.; Chandarlapaty, S.; Gosselin, A.; Celanovic, M.; Campone, M.
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Dose-escalation study of SAR439859, an oral selective estrogen receptor (ER) degrader (SERD), in postmenopausal women with ER+/HER2- metastatic breast cancer (mBC)

Meeting Abstract

Bardia, A.; Linden, H. M.; Ulaner, G. A.; Chandarlapaty, S.; Gosselin, A.; Doroumian, S.; Celanovic, M.; Campone, M.
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Defining the heterogeneity landscape of pancreatic cancer copy number alterations

Meeting Abstract

Baslan, T.; Wu, J.; Cheung, Y. H.; Bermeo, J.; Dimitrova, N.
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Evaluation of the patient-reported outcomes common terminology criteria for adverse events (PRO-CTCAE) with abiraterone acetate plus prednisone (AAP), degarelix (D), or the combination in men with biochemically recurrent prostate cancer (BCRPC)

Meeting Abstract

Autio, K. A.; Antonarakis, E. S.; Baser, R.; Stein, M. N.; Shevrin, D. H.; Vaishampayan, U. N.; Mayer, T. M.; Morris, M. J.; Slovin, S. F.; Heath, E. I.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Squamous-cell carcinoma variant histology (SCC-VH) in muscle-invasive bladder cancer (MIBC): A comprehensive clinical, genomic, and therapeutic assessment from multiple datasets

Meeting Abstract

Bandini, M.; Pederzoli, F.; Madison, R.; Briganti, A.; Plimack, E. R.; Ross, J. S.; Niegisch, G.; Yu, E. Y.; Bamias, A.; Agarwal, N.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Elucidation of qualitative patient-reported outcome (PRO) data using latent dirichlet allocation (LDA) in patients (pts) undergoing radical cystectomy

Meeting Abstract

Atkinson, T. M.; Rapkin, B. D.; Schofield, E.; Bochner, B. H.; Li, Y.
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Phase 1 study of LY3022855, a colony-stimulating factor-1 receptor (CSF-1R) inhibitor, in patients with metastatic breast cancer (MBC) or metastatic castration-resistant prostate cancer (MCRPC)

Meeting Abstract

Autio, K. A.; Klebanoff, C. A.; Schaer, D.; Kauh, J. S.; Slovin, S. F.; Blinder, V. S.; Comen, E. A.; Danila, D. C.; Hoffman, D. M. J.; Kang, S.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save